We have collected information about Albumin Based Drug Delivery for you. Follow the links to find out details on Albumin Based Drug Delivery.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769556/
Feb 27, 2016 · Albumin-based drug delivery strategies The natural transport function, multiple ligand binding sites, and cellular interactions provides rational for the exploitation of albumin for drug delivery. The ability to covalent and non-covalently attach drugs or expression of albumin-drug fusions provides a range of design options (Fig. 2 ) that has ...Author: Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam, Kenneth A. Howard
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667340/
Aug 23, 2017 · Albumin-based nanoparticles could be loaded with other chemotherapeutic drugs and inhibitors for targeted drug delivery to reduce side effects 97, 104-109. Co-loading of different chemotherapeutic drugs and inhibitors could benefit cancer treatment by …Author: Fei-Fei An, Xiao-Hong Zhang
https://molcelltherapies.biomedcentral.com/articles/10.1186/s40591-016-0048-8
Feb 27, 2016 · Albumin-based drug delivery strategies. a Albumin fusion-based drugs, in light green (HSA) and in red (fusion peptide) (modified PDB 1e7e + 3IOL).b Albumin associating drugs; upper left binding of paclitaxel (from PDB1JFF), upper right binding of insulin detemir (Levemir®) (insulin from PDB1ZNI, Myristic acid from PDB1H9Z), lower panel binding of the weakly associated warfarin …Author: Maja Thim Larsen, Matthias Kuhlmann, Michael Lykke Hvam, Kenneth A. Howard
https://www.sciencedirect.com/science/article/pii/S000186861730218X
Recently, albumin based multidrug delivery system had been developed to overcome the problems of drug resistant. Various types of anticancer agents such as a metallic agent [2-benzoylpyridine thiosemicarbazide copper II, or BpT], gene agent [AS1411] and an organic drug 5FU were combined with the albumin for combination therapy of liver cancer.Author: Bharat Bhushan, Vitaly Khanadeev, Boris Khlebtsov, Nikolai Khlebtsov, P. Gopinath
https://www.sciencedirect.com/science/article/pii/S016836591100558X
The market approval of Abraxane® can be viewed as a landmark not just for albumin-based drug delivery technology but also for nanomedicine , , , . Similarly, Kim et al. utilized nab-technology to prepare curcumin-loaded HSA nanoparticles (CCM-HSA-NPs) with a size range of 130–150 nm for intravenous administration . HSA was dissolved in water ...Author: Ahmed O. Elzoghby, Wael M. Samy, Nazik A. Elgindy
https://www.researchgate.net/publication/296478720_Albumin-based_drug_delivery_Harnessing_nature_to_cure_disease
Albumin-based drug delivery strategies. a Albumin fusion-based drugs, in light green (HSA) and in red (fusion peptide) (modified PDB 1e7e + 3IOL). b Albumin associating drugs; upper left binding ...
https://www.researchgate.net/publication/51569037_Albumin-based_nanoparticles_as_potential_controlled_release_drug_delivery_systems
Based on this caveolae-mediated transcytosis mechanism, many albumin-based drug delivery nanoparticles were developed for cancer treatment including PDAC [32][33] [34] [35][36]. One well-known ...
https://www.tandfonline.com/toc/idrd20/current
Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review. Leen Van de Sande, Sarah Cosyns, ... (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems. Pengcheng Zhang, He Tao, Liyang Yu, Lixiao Zhou & Chenggang Zhu. Pages: 491-501.
https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/mabi.201500453
Albumin has been a popular building block to create nanoparticles for drug delivery purposes. The performance of albumin as a drug carrier can be enhanced by combining protein with polymers, which allows the design of carriers to encompass a broader spectrum of drugs while features unique to synthetic polymers such as stimuli‐responsiveness are introduced.Author: Yanyan Jiang, Martina Stenzel
https://pubs.acs.org/doi/10.1021/bc1002295
Apr 01, 2011 · Albumin nanoparticles as nanocarriers for drug delivery: Focusing on antibody and nanobody delivery and albumin-based drugs. Journal of Drug Delivery Science and Technology 2020, 55, 101471. DOI: 10.1016/j.jddst.2019.101471.Author: Rongzuo Xu, Michael Fisher, R. L. Juliano
Searching for Albumin Based Drug Delivery?
You can just click the links above. The data is collected for you.
